Abstract:Coumarin‐1,3,5‐triazine derivative 3 b has the strongest inhibitory effect on AChE (IC50=0.018 μM), which is closest to the IC50 of the positive control donepezil (IC50=0.016 μM). Compound 3 b is a mixed‐type AChE inhibitor. Compound 3 b can stably interact with key amino acids in the CAS and PAS of AChE. A series of coumarin‐1,3,5‐triazine derivatives were designed, synthesized and evaluated as acetylcholinesterase inhibitors. The structures of those compounds were characterized by IR, NMR, HRMS, HPLC, and X‐ray. The structures of those coumarin‐1,3,5‐triazine derivatives are the mixtures of two geometric isomers. The 1H‐NMR of compound 3 g without coumarin structure and its hydrochloride and single crystal structure of compound 3 g were studied to prove the coumarin‐1,3,5‐triazine derivatives are the mixtures of two geometric isomers. The acetylcholinesterase and butyrylcholinesterase inhibitory activities of the synthesized compounds were determinated by Ellman's method. The results showed that all the compounds could inhibit acetylcholinesterase selectively. Among them, compound 3 b was found to have the strongest inhibitory effect on acetylcholinesterase with an IC50 value of 0.018 μM, which was closest to the IC50 of the positive control donepezil (IC50=0.016 μM). Enzyme kinetic studies indicate that this compound inhibited acetylcholinesterase with a mixed mode. Molecular docking, molecular dynamics simulation study and binding free energy calculation experiments demonstrated that compound 3 b could stably interact with key amino acids in the catalytically active site and the peripheral anion site of acetylcholinesterase. According to the results, compound 3 b demonstrates promising potential as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.

Design, synthesis and biological evaluation of new carbazole-coumarin hybrids as dual binding site inhibitors of acetylcholinesterase

Structure–activity Relationship Investigation of Coumarin–chalcone Hybrids with Diverse Side-Chains As Acetylcholinesterase and Butyrylcholinesterase Inhibitors

Design, Synthesis, Biological Evaluation and Docking Study of 4-Isochromanone Hybrids Bearing N-benzyl Pyridinium Moiety As Dual Binding Site Acetylcholinesterase Inhibitors

Design, synthesis, biological evaluation, and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors (part II).

Synthesis and biological evaluation of novel flavonoid derivatives as dual binding acetylcholinesterase inhibitors.

Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Quinoline-Ferulic Acid Hybrids As Cholinesterase Inhibitors.

Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors

Design, synthesis, biological evaluation, and docking study of 4-isochromanone hybrids bearing <i>N</i> -benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors (part II)

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chalcone-Rivastigmine Hybrids As Cholinesterase Inhibitors

Design, Synthesis and Pharmacological Evaluation of Chalcone Derivatives As Acetylcholinesterase Inhibitors

Design,Synthesis and Characterization of Inhibitors for Acetylcholinesterase(AChE)

2-(2-Indolyl-)-4(3h)-quinazolines Derivates As New Inhibitors of AChE: Design, Synthesis, Biological Evaluation and Molecular Modelling

Design, Synthesis and Bioactivity Evaluation of Coumarin–BMT Hybrids as New Acetylcholinesterase Inhibitors

Design, Synthesis and Anticholinesterase Activity of Coumarin‐1,3,5‐triazine Derivatives

Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease

Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies

Design, Synthesis, and Acetylcholinesterase Inhibitory Activity of Novel Coumarin Analogues

Design, Synthesis and Evaluation of Difunctionalized 4-Hydroxybenzaldehyde Derivatives As Novel Cholinesterase Inhibitors

Design, Synthesis and Evaluation of Novel Tacrine-Multialkoxybenzene Hybrids As Dual Inhibitors for Cholinesterases and Amyloid Beta Aggregation

Syntheses of Coumarin–tacrine Hybrids As Dual-Site Acetylcholinesterase Inhibitors and Their Activity Against Butylcholinesterase, Aβ Aggregation, and Β-Secretase